Bayer facing second trial over glyphosate in Roundup

ConsumerAffairs - 02-25

0LGnknN4

Bayer, the company that purchased Monsanto in June, is facing a second trial today over the controversial active ingredient in its weed-killing product Roundup. The trial comes six months after Dewayne Johnson, a former school groundskeeper with non-Hodgkin’s lymphoma, won a lawsuit alleging that the glyphosate contained in the herbicide causes cancer.